Study Predicts COPD Epidemic in 20 Years, Potentially Overwhelming Healthcare Systems

Abstract COPD is currently one of the leading causes of hospitalizations in industrialized countries. The future burden of COPD is uncertain as the trends in the prevalence of the main risk factors for COPD, namely cigarette smoking and population aging, are moving in opposite directions in many jurisdictions. Here, we used data from British ColumbiaContinue reading “Study Predicts COPD Epidemic in 20 Years, Potentially Overwhelming Healthcare Systems”

The disease burden of chronic obstructive pulmonary disease in Greece

This survey provides insightful data regarding the impact of COPD on Greek patients’ everyday life, psychology, and productivity, revealing the increased individual morbidity and the significant burden of this condition on society. International Journal of Chronic Obstructive Pulmonary Disease, 2016 Volume 2016:11(1) Pages 2179—2189 Authors Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N Background: The objectiveContinue reading “The disease burden of chronic obstructive pulmonary disease in Greece”

Community pharmacist program improves COPD care

Br J Clin Pharmacol 2013; Advance online publication Patients with chronic obstructive pulmonary disease (COPD) who receive a community pharmacist-based intervention have improved inhalation technique and medication adherence, show the results of a randomized trial. Findings from the PHARMAceutical Care for COPD (PHARMACOP) study, published in the British Journal of Clinical Pharmacology, also suggest thatContinue reading “Community pharmacist program improves COPD care”

Novel Drug Has Dual Action in Asthma, COPD

A novel inhaled drug appeared safe as a dual bronchodilator and anti-inflammatory in asthma and chronic obstructive pulmonary disease (COPD), a series of proof-of-concept studies showed. In COPD patients, nebulized RPL554 boosted forced expiratory volume in 1 second (FEV1) by 17% versus placebo, with peak effects comparable to inhaled beta-2 agonists, Clive P. Page, PhD,Continue reading “Novel Drug Has Dual Action in Asthma, COPD”

Sexual dysfunction ‘ignored in COPD’

Multidiscip Respir Med 2013; 8: 66 Researchers say that physicians should address sexual issues in patients with chronic obstructive pulmonary disease (COPD) as a matter of course, after finding that over three-quarters of men with the condition have some level of erectile dysfunction. However, despite this having been recognized by several studies, the condition isContinue reading “Sexual dysfunction ‘ignored in COPD’”

Hypothyroidism linked to COPD exacerbation risk

Research shows that chronic obstructive pulmonary disease (COPD) patients with hypothyroidism have an elevated exacerbation frequency but, despite this, experience similar quality of life to patients with normal thyroid function. The research team, led by Sevinc Sarinc Ulasli (Afyon Kocatepe University, Turkey), studied a group of 44 COPD patients with hypothyroidism, 44 with COPD andContinue reading “Hypothyroidism linked to COPD exacerbation risk”